Log In
BCIQ
Print this Print this
 

birinapant (formerly TL32711)

  Manage Alerts
Collapse Summary General Information
Company TetraLogic Pharmaceuticals Corp.
DescriptionSmall molecule peptidomimetic of diablo homolog (DIABLO; SMAC) that selectively antagonizes multiple inhibitor of apoptosis (IAP) proteins
Molecular Target Inhibitor of apoptosis (IAP)
Mechanism of ActionInhibitor of apoptosis (IAP) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat HBV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/20/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today